Aerobiotix named to INC. 5000 list of Fastest-Growing Private Companies | Aerobiotix

Aerobiotix named to INC. 5000 list of Fastest-Growing Private Companies

Aug 25, 2021 | News, News and Events


Healthcare air quality solutions company ranks #304 with 3-year revenue growth of 1,503%

For Immediate Release

Download PDF

[MIAMISBURG, OHIO] — Inc. magazine revealed the 2021 list of the fastest growing companies in America and Aerobiotix, an innovative medical device company, ranked 304th out of 5,000. Aerobiotix is on a mission to improve the air quality in operating rooms with clinically-proven technology, resulting in 3-year revenue growth of 1,503%.

Landing in the top 6% of companies is a key milestone for the Ohio-based manufacturer of nonturbulent ultraclean air systems for healthcare facilities. Their patented Illuvia® system reduces the risk of infection and contamination of infectious aerosols including SARS-COV-2. Aerobiotix technology is currently being used by over 150 healthcare facilities worldwide.

“Earning a top spot on the Inc. 5000 list underscores the value we have brought to healthcare during these challenging times,” said David Kirschman, M.D., president and CEO of Aerobiotix. “There’s rapidly growing demand for clinically proven solutions to increase the safety of patients and staff during surgical procedures.”

Inc.’s editor-in-chief Scott Omelianuk called this “one of the most important rosters of companies ever compiled” in light of the pandemic. Among the honorees, more than 610,000 jobs have been created over the past three years. Complete results of the Inc. 5000, including company profiles and an interactive database can be found at


About Aerobiotix
Aerobiotix is a pioneer in air quality management solutions for healthcare, assisted living, and education. Its medical-grade products use ultraviolet light, HEPA filters, and proprietary filtration to remove 99.9% of bacteria, viruses, VOCs, and more. This proven technology is quiet, safe, and designed to run continuously in occupied rooms to reduce risk of infections and to improve environmental safety. Equipped with integrated tracking, Aerobiotix solutions help facilities worldwide measure and proactively manage air quality. Learn more at

Contact Information
Kristin Porco | 616.717.3511

Download PDF



Sr. Vice President of Global Sales and Marketing

Jason leads our global sales team and brings over 18 years of Medical Device experience to Aerobiotix. Jason has led top performing National and Regional Sales teams, selling disruptive technology in the Cardiovascular space with Getinge, Surgical Robotics at Hansen Medical and most recently in the Biologics space with Axogen. Jason received his Bachelor of Science Degree from the University of Indianapolis.



Vice President of Global Marketing

Melissa Gietzen, MBA is a highly skilled strategic marketing professional with over 20 years’ experience in the healthcare industry. She has significant expertise in strategic planning, capital budgeting, service improvement projects, and creating strong successful brands in the orthopedic, cardiac & ophthalmology markets. Melissa holds a undergraduate degree in Management and Organization Development and a masters degree in Business Administration.



President and CEO

The founder and CEO is David Kirschman, M.D., a former physician with extensive experience as CEO, Director, Chief Scientific Officer and operator in the orthopedic and biologic medical device space. Dr. Kirschman holds 55 issued US Patents for a wide range of medical devices. He received his BS in Biological Science cum laude from Colorado State University and M.D. from University of Colorado School of Medicine.

GREGORY CARROLL PH.D. Director Scientific Affairs


Director Scientific Affairs

Dr. Carroll has extensive experience in ultraviolet and photonic science. Prior to joining Aerobiotix, he led the research and development group at Sunstar Engineering. He has a Ph.D. in chemistry from Columbia University and did his postdoctoral fellowship under Nobel laureate Prof. Ben Feringa at the University of Groningen, Netherlands, and Lawrence Berkeley National Laboratory.

TONY EMBREE Chief Commercial Officer


Chief Commercial Officer

Tony leads our global sales organization and commercialization strategy. Prior joining Aerobiotix, he was Senior Manager of Strategy at Stryker. He has led sales and marketing teams in multiple organizations including SurgiCount Medical, part of Patient Safety Technologies, INC (PSTX) as it expanded from 8 hospitals in 2008 to user base of 330 hospitals at time of acquisition in 2013.

COURTNEY ADAMS, Ph.D. VP of Clinical and Medical Affairs


VP of Clinical and Medical Affairs

Dr. Adams leads our global clinical research and education initiatives as well as developing key opinion leaders to support our clinical mission. Prior to joining Aerobiotix, she held leading research and medical affairs roles at Biogen, Axogen, and MedPace. Dr. Adams holds Ph.D. in Pharmacology from University of Cincinnati.

ANTHONY DEFALCO Vice President of Engineering


Vice President of Engineering

Anthony is a topflight medical device product development engineer and leader, experienced in the development and implementation of orthopedic, environmental, and electromechanical systems.

NATHAN UTZ Vice President of Client Services


Vice President of Strategic Accounts

Nathan brings a high level of commitment to servicing and building client relations. Nathan has previously held leadership roles in the medical device industry.

MICHAEL SCHMITZ Chief Financial Officer


Chief Financial Officer

Mr. Schmitz is a highly experienced financial practitioner with financial leadership roles in diverse industries including manufacturing and technology as well as a background in public accounting. He received his BS in accounting, cum laude, from the Miami University of Ohio. Mr. Schmitz is a certified public accountant and certified management accountant.